Search clinical trials for: Cariprazine

Total 46 results

Gedeon Richter Plc.

Completed

Cariprazine: Comparison of Slow- and Immediate-release Forms

Pharmacokinetic Profile

United Kingdom
Mitsubishi Tanabe Pharma Corporation

Completed

Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia

Schizophrenia

Japan
AbbVie

Withdrawn

A Study To Assess Adverse Events and Change in Disease Activity With Oral Cariprazine When Added to Antidepressant Therapies (ADTs) Compared to Placebo in Adult Participants With Generalized Anxiety Disorder (GAD) Who Have Had an Inadequate Response to ADTs Alone (CAR aGAD Ph 2)

Generalized Anxiety Disorder

United States
Whanin Pharmaceutical Company

Enrolling by invitation

Study Evaluating the Efficacy and Safety of WID-RGC20(Cariprazine) in Patients With Schizophrenia

Schizophrenia

Korea, Republic of
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar Depression

Bipolar Depression

United States
AbbVie

Recruiting

Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder

Schizophrenia | Bipolar I Disorder | Autism Spectrum Disorder (ASD)

United States, Puerto Rico
Forest Laboratories
Gedeon Richter Ltd.

Completed

Study Evaluating Cariprazine (RGH-188) in the Treatment of Patients With Acute Mania

Bipolar Disorder

United States
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder

Major Depressive Disorder

United States
Anna Rose Childress, Ph.D.
National Institute on Drug Abuse (NIDA)

Terminated

Cariprazine Effects on Brain and Behavior in Cocaine Use Disorder

Cocaine Use Disorder

United States
Kyle Kampman
National Institute on Drug Abuse (NIDA)

Recruiting

Cariprazine for Comorbid Cocaine and Opioid Use Disorder

Opioid-use Disorder | Cocaine Use Disorder

United States
Dr. Martin A. Katzman

Recruiting

Adjunct Treatment With Cariprazine for Adults With Attention-deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

Canada
Forest Laboratories

Completed

Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder

Depression | Bipolar Disorder

United States, Bulgaria, Serbia, Ukraine, Croatia, Romania, Puerto Rico, Slovakia
AbbVie

Completed

A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features

Depression | Mania | Bipolar I Disorder

United States, Bulgaria, Korea, Republic of, Malaysia, Poland, Puerto Rico, Russian Federation, Serbia, Taiwan, Thailand, Ukraine
AbbVie

Completed

Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone

Major Depressive Disorder

United States, Bulgaria, Estonia, Germany, Hungary, Ukraine, United Kingdom
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression

Depression, Bipolar

United States, Ukraine, Bulgaria, Canada, Colombia, Russian Federation
New York State Psychiatric Institute

Not yet recruiting

Dopamine D3 Receptor Occupancy in Bipolar Depression

Bipolar Depression

United States
AbbVie

Recruiting

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

Depression | Bipolar I Disorder

United States, Puerto Rico, Russian Federation
Forest Laboratories
Gedeon Richter Ltd.

Completed

A Study of Cariprazine in Patients With Chronic Stable Schizophrenia

Schizophrenia

United States, India, Malaysia, Russian Federation, Ukraine
Forest Laboratories

Completed

Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression

Depression | Bipolar Disorder

United States, Bulgaria, Poland, Puerto Rico, Lithuania, Estonia
AbbVie

Recruiting

Study to Assess Adverse Events and Change in Disease Activity of Oral Cariprazine Capsules in Adult Participants With Schizophrenia

Schizophrenia

Japan, Taiwan
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine for Mania

Bipolar Disorder | Mania

United States, India
AbbVie

Terminated

Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With Schizophrenia

Schizophrenia

United States, Serbia, Korea, Republic of, Malaysia, Poland, Bulgaria, Ukraine, Puerto Rico, Romania, Taiwan, Thailand
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine for Bipolar I Disorder

Mania | Bipolar I Disorder

United States, Croatia, Romania, Russian Federation, Serbia, Ukraine
Gedeon Richter Plc.

Recruiting

Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia

Schizophrenia

Mexico, United States, Bulgaria, Colombia, Romania, Russian Federation, Serbia, Ukraine
AbbVie

Completed

Cariprazine Pediatric ASD PK Study

Autism Spectrum Disorder

United States
Forest Laboratories
Gedeon Richter Ltd.

Completed

Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder

Bipolar I Disorder

United States, Hungary, Poland, Spain
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine in Schizophrenia

Schizophrenia

United States, Colombia, India, South Africa
Sultan Qaboos University

Not yet recruiting

Effectiveness of Cariprazine Monotherapy for Treatment of Major Depressive Disorder

Depressive Disorder, Major
Jayasree Basivireddy

Recruiting

Assessing the Role of Cariprazine in Improving Cognition in Euthymic Bipolar Patients (CARPZ-01)

Cognitive Impairment | Bipolar I Disorder

Canada
Forest Laboratories
Gedeon Richter Ltd.

Completed

A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia

Schizophrenia

United States, India, Romania, Slovakia, Ukraine
Forest Laboratories

Completed

Study Evaluating RGH-188 in the Treatment of Patients With Schizophrenia

Schizophrenia

United States
Forest Laboratories
Gedeon Richter Ltd.

Completed

Long-term Study of Cariprazine in Patients With Schizophrenia

Schizophrenia

United States, Colombia, India, Romania, Russian Federation, Ukraine
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Major Depressive Disorder

United States, Estonia, Finland, Slovakia, Sweden, Ukraine
The Medical Research Network
AbbVie

Not yet recruiting

Cariprazine Versus Placebo for Social Anxiety Disorder

Social Anxiety Disorder

United States
AbbVie

Recruiting

Study of Cariprazine Oral Capsules or Solution to Assess Adverse Events and Change in Irritability Due to Autism Spectrum Disorder (ASD) in Participants Aged 5-17 Years With ASD

Autism Spectrum Disorder

United States, Puerto Rico
AbbVie

Completed

The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone

Major Depressive Disorder

United States, Canada, Czechia, Finland, Poland, Puerto Rico, Serbia, Slovakia
Rabin Medical Center

Unknown

A Comparison Between Bandage Contact Lens, Punctal Plugs and Standard Measures in Preventing Corneal Injuries (COMLENPLSTAN)

Contact Lens and Punctal Plug in Preventing Corneal Injuries

Israel
Aalborg University Hospital
Mental Health Center, Glostrup; Mental Health Center North Zealand; Mental Health... and other collaborators

Recruiting

Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9) (DUAG9)

Depression, Bipolar

Denmark
Forest Laboratories
Gedeon Richter Ltd.

Completed

Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive Disorder

Major Depressive Disorder

United States, Puerto Rico
Forest Laboratories
Gedeon Richter Ltd.

Completed

Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States, Puerto Rico
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of Schizophrenia

Schizophrenia

United States, India, Russian Federation, Malaysia, Ukraine
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine in Patients With Schizophrenia

Schizophrenia

United States, Romania, Russian Federation, Ukraine
Ohio State University

Recruiting

An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine

Treatment-resistant Schizophrenia

United States
Forest Laboratories

Completed

Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia

Schizophrenia

United States
Celgene

Completed

Drug-drug Interaction Study of Ozanimod With Inhibitor or Inducer of CYP2C8 and/or CYP3A

Healthy Volunteer

United States
Russell Richardson

Recruiting

: Vascular Function in Health and Disease

Heart Failure | Hypertension | Chronic Obstructive Pulmonary Disease | Pulmonary Artery Hypertension

United States

Search clinical trials for: Cariprazine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations